Overall rank by patents
#31,962
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 6 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).
The verdict
Hudson holds 8 US patents across 6 technology areas, rank #31,962 of 50,000 tracked assignees.
Hudson Institute Of Medical Research has been granted 8 US utility patents between 2021 and 2025, placing Hudson Institute Of Medical Research at rank #31,962 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.3 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, Hudson Institute Of Medical Research is one of the more focused assignees in the PatentsView dataset. By volume, Hudson sits between Hooker Furniture Corporation (8 patents, rank #31,958) and Hupa International, Inc. (8 patents, rank #31,966) - the closest US assignees by grant volume. The composite Innovation Score of 28.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 8 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Hudson Institute Of Medical Research's 12.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Hudson Institute Of Medical Research against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Hooker Furniture Corporation
8 patents
Hoowaki, LLC
8 patents
Horizon (Shanghai) Artificial Intelligence Technology Co., Ltd.
8 patents
Horizon Therapeutics Ireland DAC
8 patents
Hughes Furniture Industries, Inc.
8 patents
Human BioMolecular Research Institute
8 patents
Huntar Company
8 patents
Hupa International, Inc.
8 patents
Hudson Institute of Medical Research
8 patents
What this shows Hudson holds 8 patents at rank #31,962, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #31,962 in granted patent volume.
Other assignees with the most granted patents in Hudson's primary technology class.
Hudson's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
29 Top 72% higher than 28% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 4 | 50.0% |
| 2022 | 1 | 12.5% |
| 2023 | 2 | 25.0% |
| 2025 | 1 | 12.5% |
Top 6 of 6 technology areas
Overall rank by patents
#31,962
Across all tracked assignees
28.6 out of 100
How to use this portfolio
Hudson's 8 grants land it in the top 72% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.